Vantage Foundation partners Instituto Claret to uplift underprivileged in Brazil
SAO PAULO, March 27, 2024 /PRNewswire/ — Vantage Foundation is pleased to announce its partnership with Instituto Claret, a reputable charitable organisation in Brazil. Vantage Foundation partners Instituto Claret to uplift underprivileged in Brazil Instituto Claret offers a range of programmes including...
Vantage Markets' #TradeForHope Campaign Raises Vital Funds for Instituto Claret in Brazil
PORT VILA, Vanuatu, March 27, 2024 /PRNewswire/ — Multi-asset broker Vantage Markets ("Vantage") recently concluded its #TradeforHope initiative, dedicated to supporting Instituto Claret, a prominent charity organisation in Brazil. Vantage Markets’ #TradeForHope Campaign Raises Vital Funds for Instituto Claret in Brazil Instituto...
Cognizant Continues Collaboration with Pon IT to Further Manage and Optimize Cloud Services
The extended relationship will enable Cognizant to continue providing managed services to the cloud platform for Pon IT and its numerous operating companies to enhance agility, intuition, and innovation. TEANECK, N.J., March 27, 2024 /PRNewswire/ — Cognizant (Nasdaq: CTSH) has...
Entity under Doo Financial Granted Capital Markets Services (CMS) License by Monetary Authority of Singapore (MAS)
HONG KONG, March 27, 2024 /PRNewswire/ — Recently, Doo Capital Market SG Pte. Ltd. ("DCM"), an entity under Doo Financial, has officially been granted with a Capital Markets Services (CMS) license (License Number: CMS101428) from Monetary Authority of Singapore (MAS). Doo...
Infobip named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Global cloud communications platform joins the ranks of Nvidia, YouTube, Taco Bell, and more KUALA LUMPUR, Malaysia, March 27, 2024 /PRNewswire/ — Global cloud communications platform Infobip has been named to Fast Company‘s prestigious list of the World’s Most Innovative Companies of...
Breaking new ground in water management technology, KISTERS introduces HyQuant: the affordable, all-in-one non-contact water level and velocity radar sensor
A new approach from KISTERS combines water level and velocity measurement in a single compact sensor, overcoming cost barriers. This development increases efficiency by eliminating the need to integrate independent sensors in one housing, leading to significant benefits to water-dependent...
Omdia: Global semiconductor supply chain set to see growth in 2024 as GenAI demand increases
LONDON, March 27, 2024 /PRNewswire/ — New research from Omdia has revealed that the global semiconductor supply chain is forecasted to reach approximately $600 billion by 2024, having navigated through strategic inventory adjustments in recent quarters. Encouragingly, the semiconductor industry...
Don't miss out on the opportunity to be a part of CWIEME Shanghai 2024
SHANGHAI, March 27, 2024 /PRNewswire/ — Join us on the next exciting journey at CWIEME Shanghai 2024 (shanghai.cwiemeevents.com) on June 26-28 at Shanghai World Expo Exhibition & Convention Center! Visitor registration for the exhibition is in full swing. Don’t miss out, CLICK HERE to register! As a global coil winding and electrical manufacturing event, CWIEME Shanghai builds an...
New Study Finds GenAI as Top Tech Investment for Manufacturers, While 94% Expect to Maintain or Expand Their Workforce
Global State of Smart Manufacturing Report reveals impact of emerging technologies on addressing workforce, quality, cybersecurity, and sustainability challenges SINGAPORE, March 27, 2024 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation,...
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology
SEONGNAM, South Korea and AURORA, Colo., March 27, 2024 /PRNewswire/ — Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Raul Torres’s Lab at the University...
FP Markets Named Best In Class for Commissions & Fees, Algo Trading and MetaTrader
SYDNEY, March 27, 2024 /PRNewswire/ — Celebrating nearly two decades in the Forex and CFDs industry, FP Markets continues to excel in meeting the needs of traders and investors, earning it repeated industry acknowledgement in numerous key areas. The Best-In-Class...
Adventurer Lexie Limitless Completes Record-Setting 30,000 km Drive Around the World in New All-Electric Ford Explorer
NICE, France, March 27, 2024 /PRNewswire/ — Adventurer Lexie Alford (@LexieLimitless) today set the official record for being the first person to circumnavigate the globe in an electric vehicle, using the new all-electric Ford Explorer. Six continents, 27 countries and more...
Shanghai Electric Advances Wind Energy Technology with Innovative Blade Roughness Estimation Method by Senior Expert Koji Fukami
ROSKILDE, Denmark, March 26, 2024 /PRNewswire/ — In a significant development for the wind energy sector, Shanghai Electric Wind Power Group, a subsidiary of Shanghai Electric (SEHK:2727, SSE:601727), a company renowned for its dedication to clean energy equipment, recently celebrated the fifth...
OVHcloud® US and OneNeck® Announce Strategic Partnership to Enhance Nutanix Offering
RESTON, Va., March 26, 2024 /PRNewswire/ — OVHcloud US, a leading global cloud provider, and OneNeck IT Solutions LLC, a leading provider of hybrid IT and multi-cloud solutions and services, are excited to announce a strategic partnership designed to deliver...
Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients
– New research published in Clinical Cancer Research shows significant improvement in distant recurrence-free survival with combined durvalumab and tremelimumab treatment, supported by Lunit SCOPE IO’s analysis of tumor microenvironment SEOUL, South Korea, March 26, 2024 /PRNewswire/ — Lunit (KRX:328130.KQ),...
TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710, a Long-acting Recombinant Activated Factor VII, in Hemophilia A or B Patients
TU7710 has the potential to be a highly effective and long-acting treatment for bleeding episodes as well as for preventing bleeding during surgery or invasive procedures in hemophilia patients with inhibitors Interim results from an ongoing Phase 1a study in...